As of 2026-09-13, the Intrinsic Value of Ampio Pharmaceuticals Inc (AMPE) is -1,338.70 USD. This Ampio valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.18 USD, the upside of Ampio Pharmaceuticals Inc is -731,230.50%.
Based on its market price of 0.18 USD and our intrinsic valuation, Ampio Pharmaceuticals Inc (AMPE) is overvalued by 731,230.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1,338.70 - -1,338.70 | -1,338.70 | -731,230.50% |
| P/E | (449.80) - (530.12) | (522.09) | -285240.6% |
| DDM - Stable | (2,264.69) - (14,418.05) | (8,341.37) | -4555734.0% |
| DDM - Multi | (1,960.00) - (10,397.36) | (3,372.57) | -1842025.4% |
| Market Cap (mil) | 0.01 |
| Beta | 129.28 |
| Outstanding shares (mil) | 0.03 |
| Enterprise Value (mil) | -4.08 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.97% |
| Cost of Debt | 5.00% |
| WACC | 6.32% |